Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. This position reports to the Executive Director, Data Management, Oncology and is part of the Data Management Oncology organization, which supports high-quality clinical trial execution through data oversight, risk identification, documentation, analytics, and cross-functional study support. The role is responsible for providing study-level leadership for Risk Based Quality Management (RBQM) across Phase 1 to Phase 4 oncology clinical trials and works closely with Clinical Operations, Data Management, Biostatistics, Clinical Project Teams, Quality, and other partner functions to ensure proactive risk assessment, centralized monitoring, mitigation planning, inspection readiness, and aligned execution of SMPA RBQM strategy.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level